EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human iPSC Models for Functional Interpretation of Congenital Heart Disease Variants of Uncertain Significance

José Bragança, Rómio Pinto, Pedro dos Santos Encarnação, Kelly Felício, Mafalda Lázaro, Bárbara Silva, Shally Sharma, Rute Luísa Cabrita Pinto

Journal of Personalized Medicine · 09.11.2026 · 16 (11) · 575

DOI: 10.3390/jpm16110575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 09.11.2026. Verfasst von José Bragança und 7 weiteren Autor:innen. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia (FCT) Portugal, Universidade do Algarve, “Partnerships for Excellence” action.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Variants of uncertain significance (VUS) complicate the genetic diagnosis and clinical interpretation of congenital heart disease (CHD). Human induced pluripotent stem cells (iPSCs) can model patient-specific genetic backgrounds, relevant cardiac cell types, and developmental processes, providing an opportunity to investigate variant effects in biologically relevant human systems. However, the observation of a cellular or molecular phenotype alone does not establish functional evidence for pathogenicity or benignity. Interpreting such phenotypes requires careful consideration of genetic background, experimental variability, developmental stage, cardiac lineage, and the biological relevance of the selected model and assay endpoint. Isogenic controls, independent iPSC clones, and reproducible phenotyping strategies can help distinguish variant-specific effects from background or assay-related variation. This review proposes a question-first framework for model selection, isogenic testing, prespecified phenotyping, replication, and calibration assay with emphasis on matching the experimental system to the established disease mechanism. Collectively, this framework defines when iPSC-based findings are sufficiently robust, reproducible, and disease-relevant to contribute to ACMG/AMP PS3 or BS3 evidence and support the functional interpretation of CHD-associated VUS.

Förderung

  • Fundação para a Ciência e Tecnologia (FCT) Portugal
  • Universidade do Algarve
  • “Partnerships for Excellence” action

Zitieren

APA

Bragança, J., Pinto, R., Encarnação, P. D. S., Felício, K., Lázaro, M., Silva, B., Sharma, S., & Pinto, R. L. C. (2026). Human iPSC Models for Functional Interpretation of Congenital Heart Disease Variants of Uncertain Significance. Journal of Personalized Medicine, 16(11), 575. https://doi.org/10.3390/jpm16110575

Vancouver

Bragança J, Pinto R, Encarnação PDS, Felício K, Lázaro M, Silva B, et al. Human iPSC Models for Functional Interpretation of Congenital Heart Disease Variants of Uncertain Significance. Journal of Personalized Medicine. 2026;16(11):575. doi:10.3390/jpm16110575

BibTeX
@article{Bragana2026,
  author = {Bragança, José and Pinto, Rómio and Encarnação, Pedro dos Santos and Felício, Kelly and Lázaro, Mafalda and Silva, Bárbara and Sharma, Shally and Pinto, Rute Luísa Cabrita},
  title = {Human iPSC Models for Functional Interpretation of Congenital Heart Disease Variants of Uncertain Significance},
  journal = {Journal of Personalized Medicine},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {575},
  doi = {10.3390/jpm16110575}
}
Kostenlos starten →